English
简体中文
繁體中文
English
Filipino
हिन्दी
Hmong
Bahasa Indonesia
日本語
Basa Jawa
한국어
ພາສາລາວ
Bahasa Melayu
മലയാളം
ဗမာစာ
سنڌي
தமிழ்
ไทย
Tiếng Việt
Afrikaans
Shqip
العربية
አማርኛ
Հայերեն
Azərbaycan dili
Euskara
Беларуская мова
বাংলা
Bosanski
Български
Català
Cebuano
Chichewa
Corsu
Italiano
Hrvatski
Čeština
Dansk
Nederlands
Esperanto
Eesti
Suomi
Frysk
Galego
ქართული
Ελληνικά
ગુજરાતી
Kreyol ayisyen
Deutsch
Français
Harshen Hausa
Ōlelo Hawaiʻi
עִבְרִית
Magyar
Íslenska
Igbo
Gaeilge
ಕನ್ನಡ
Қазақ тілі
ភាសាខ្មែរ
كوردی
Кыргызча
Latin
Latviešu valoda
Lietuvių kalba
Lëtzebuergesch
Македонски јазик
Malagasy
Maltese
Te Reo Māori
मराठी
Монгол
नेपाली
Norsk bokmål
پښتو
فارسی
Polski
Português
ਪੰਜਾਬੀ
Română
Русский
Samoan
Gàidhlig
Српски језик
Sesotho
Shona
සිංහල
Slovenčina
Slovenščina
Afsoomaali
Español
Basa Sunda
Kiswahili
Svenska
Тоҷикӣ
తెలుగు
Türkçe
Українська
اردو
O‘zbekcha
Cymraeg
isiXhosa
יידיש
Yorùbá
ZuluEnvista Holdings Corporation (NYSE: NVST) has announced the appointment of Paul Keel as chief executive officer and member of the board of directors, effective May 1, 2024. He succeeds Amir Aghdaei, who will continue to support the transition as a senior advisor.
Leadership Transition
Scott Huennekens, chairman of Envista, expressed confidence in Keel’s ability to lead the company, stating, “Paul’s strong track record as CEO of a public, diversified, global innovation company makes him the right leader for Envista at this stage in our growth journey.” Keel brings a wealth of experience in accelerating growth and operational excellence, particularly in the medical and oral care markets.
Keel expressed his enthusiasm for his new role, saying, “It’s a great honor to lead Envista at this exciting time in our deep and rich history.” He aims to build on Envista’s strong foundation and further serve all stakeholders, including customers, patients, colleagues, communities, and shareholders.
Professional Background
Prior to joining Envista, Keel held leadership positions at Smiths Group plc and spent 16 years at 3M in various capacities, including Group President of the Consumer Business Group, President of 3M Medical, and President of 3M’s Specialty Dental business. He brings extensive experience from roles at GE, McKinsey & Company, and General Mills. Keel holds a BA from Carleton College and an MBA from Harvard Business School.
About Envista
Envista is a global family of over 30 trusted dental brands, committed to partnering with professionals to improve lives. With a comprehensive portfolio covering dental implants, orthodontics, digital imaging technologies, and more, Envista helps customers deliver the best possible patient care. Grounded in continuous improvement, innovation, and customer focus, Envista is poised to meet the evolving needs of dental professionals worldwide.
For further information, please visit www.envistaco.com.
The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.
Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.
The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.